MEP38808A - Use of lh in controlled ovarian hyperstimulation - Google Patents

Use of lh in controlled ovarian hyperstimulation

Info

Publication number
MEP38808A
MEP38808A MEP-388/08A MEP38808A MEP38808A ME P38808 A MEP38808 A ME P38808A ME P38808 A MEP38808 A ME P38808A ME P38808 A MEP38808 A ME P38808A
Authority
ME
Montenegro
Prior art keywords
ovarian hyperstimulation
controlled ovarian
coh
controlled
folliculogenesis
Prior art date
Application number
MEP-388/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Stephen Hillier
Colin Michael Howles
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8182260&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP38808(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Publication of MEP38808A publication Critical patent/MEP38808A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MEP-388/08A 2001-09-12 2002-09-12 Use of lh in controlled ovarian hyperstimulation MEP38808A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01307755 2001-09-12
PCT/GB2002/004147 WO2003022301A2 (en) 2001-09-12 2002-09-12 Use of lh in controlled ovarian hyperstimulation

Publications (1)

Publication Number Publication Date
MEP38808A true MEP38808A (en) 2011-02-10

Family

ID=8182260

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-388/08A MEP38808A (en) 2001-09-12 2002-09-12 Use of lh in controlled ovarian hyperstimulation

Country Status (28)

Country Link
US (1) US7341989B2 (xx)
EP (1) EP1434600B1 (xx)
JP (1) JP2005504072A (xx)
KR (1) KR20040032953A (xx)
CN (1) CN1302806C (xx)
AR (1) AR036591A1 (xx)
AT (1) ATE427755T1 (xx)
AU (1) AU2002331939B2 (xx)
BR (1) BR0212502A (xx)
CA (1) CA2457067A1 (xx)
CY (1) CY1110487T1 (xx)
DE (1) DE60231892D1 (xx)
DK (1) DK1434600T3 (xx)
EA (1) EA009210B1 (xx)
ES (1) ES2322136T3 (xx)
HK (1) HK1067866A1 (xx)
HR (1) HRP20040070A2 (xx)
IL (1) IL160781A0 (xx)
ME (1) MEP38808A (xx)
MX (1) MXPA04002125A (xx)
NO (1) NO327154B1 (xx)
PL (1) PL205472B1 (xx)
PT (1) PT1434600E (xx)
RS (1) RS51505B (xx)
SI (1) SI1434600T1 (xx)
UA (1) UA78970C2 (xx)
WO (1) WO2003022301A2 (xx)
ZA (1) ZA200401008B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS105004A (xx) * 2002-06-07 2007-02-05 Ares Trading S.A., Metode za kontrolisanu hiperstimulaciju ovarijuma i farmaceutski kompleti koji se koriste za te metode
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
CN102296047B (zh) * 2011-08-13 2013-03-13 新疆农垦科学院 利用羔羊超排卵母细胞生产体外胚胎的方法
US9216037B2 (en) 2013-06-21 2015-12-22 Previvo Genetics, Llc Uterine lavage for embryo retrieval
US20150272622A1 (en) 2011-12-22 2015-10-01 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US9282995B2 (en) * 2011-12-22 2016-03-15 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
EP2968391A1 (en) 2013-03-13 2016-01-20 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
RU2629871C1 (ru) * 2016-03-22 2017-09-04 Сергей Михайлович Юдин Препарат для стимуляции фолликулогенеза и способ его применения
IT202000022015A1 (it) * 2020-09-18 2022-03-18 Marca Antonio La Nuovo uso dell'ormone luteinizzante

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4589402A (en) 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
US7695721B1 (en) 1999-05-07 2010-04-13 Merck Serono S.A. Gonadotrophins in the treatment anovulatory women

Also Published As

Publication number Publication date
YU21204A (xx) 2006-08-17
US7341989B2 (en) 2008-03-11
CN1302806C (zh) 2007-03-07
SI1434600T1 (sl) 2009-06-30
MXPA04002125A (es) 2004-07-08
EP1434600A2 (en) 2004-07-07
NO20040990L (no) 2004-03-08
KR20040032953A (ko) 2004-04-17
ES2322136T3 (es) 2009-06-17
IL160781A0 (en) 2004-08-31
AR036591A1 (es) 2004-09-22
PL367343A1 (en) 2005-02-21
CN1553809A (zh) 2004-12-08
ZA200401008B (en) 2005-08-31
EA200400428A1 (ru) 2004-08-26
RS51505B (sr) 2011-06-30
JP2005504072A (ja) 2005-02-10
UA78970C2 (uk) 2007-05-10
US20050049199A1 (en) 2005-03-03
EA009210B1 (ru) 2007-12-28
CY1110487T1 (el) 2015-04-29
DE60231892D1 (de) 2009-05-20
ATE427755T1 (de) 2009-04-15
WO2003022301A3 (en) 2003-04-17
WO2003022301A2 (en) 2003-03-20
PL205472B1 (pl) 2010-04-30
HK1067866A1 (en) 2005-04-22
CA2457067A1 (en) 2003-03-20
EP1434600B1 (en) 2009-04-08
HRP20040070A2 (en) 2004-10-31
AU2002331939B2 (en) 2007-10-25
DK1434600T3 (da) 2009-05-25
NO327154B1 (no) 2009-05-04
BR0212502A (pt) 2004-08-24
PT1434600E (pt) 2009-04-28

Similar Documents

Publication Publication Date Title
ES2130574T3 (es) Agentes de restriccion de las citoquinas.
MEP38808A (en) Use of lh in controlled ovarian hyperstimulation
BR9106702A (pt) Analogo de oligonucleotideos e processos para modular a producao de uma proteina por um organismo e para tratar um organismo
BR9006729A (pt) Dispositivo de reforco e de sustentacao da capa dos rotadores de uma articulacao de ombro humano
HUP0003349A2 (hu) Mellékpajzsmirigy-hormon peptidanalógok, ezeket hatóanyagként tartalmazó gyógyászati készítmények és alkalmazásuk
DE69839812D1 (de) Analoge des menschlichen interferon-alpha mit niedriger toxizität
DE69930758D1 (de) Verwendung von daptomycin
DE69033521T2 (de) Verwendung von arginin als immunstimulator
KR950031060A (ko) 골다공증 치료용 약제학적 조성물
PT1001802E (pt) Preparacao farmaceutica combinada compreendendo a hormona da paratiroide e um inibidor de reabsorcao ossea
EA200801714A1 (ru) Нетоксичные для нервной ткани плазминоген-активирующие факторы для лечения инсульта
DK0678013T3 (da) Præparater til behandling af hår
ES2135398T3 (es) Compuesto y composiciones de inhibicion de la resorcion osea.
RS50805B (sr) Upotreba fsh za lečenje neplodnosti
DE69630583D1 (de) Peptide, bronchodilator und den blutstrom verbesserndes mittel
ATE398134T1 (de) Neue analoga von nitrobenzylthioinosin
ATE433749T1 (de) Neue verwendung von rapamycin und strukturellen analoga hiervon
KR950013519A (ko) 골절 예방 및 치료용 약제
ATE374202T1 (de) Neue analoga von nitrobenzylthioinosin
PT1007085E (pt) Utilizacao da hormona de crescimento em composicoes para o tratamento da resistencia a insulina no coracao
EA201000501A1 (ru) Фармацевтическая композиция, содержащая не обладающий нейротоксичностью активатор плазминоген для лечения удара
BR0212274A (pt) Uso de estrogênios não-feminilizantes como agentes retinoprotetores para o tratamento de glaucoma
ATE412669T1 (de) Calicitonin-analoga mit stark erhöhter hypocalcämischer wirkung in vivo
ATE196465T1 (de) Analoge von difluoro-staton
LT2002105A (en) Novel use of siberian fir oil